LLY News and Press, Eli Lilly and Company From 03/31/24

2024-03-31 09:45:00 ET Bear markets come and go, but history has taught investors time and time again that bull markets not only tend to outlast these periods, but eventually drive stocks higher than before the downturn hit. Both bull and bear markets can present opportunities for the long-...

2024-03-31 02:10:00 ET Summary Eli Lilly and Novo Nordisk have created what Wall Street believes will be the biggest ever pharmaceutical market with its miraculous weight loss drugs. Novo Nordisk's Ozempic and Wegovy, as well as Eli Lilly's Mounjaro and Zepbound, have already gene...

2024-03-30 12:13:00 ET The Health Care Select Sector SPDR Fund ETF ( NYSEARCA: XLV ), tracking the healthcare companies under S&P 500, rose 8.32% in the first quarter of 2024, lagging slightly behind the broader S&P 500 index which rose 10.16%.... Read the full article...

2024-03-30 06:50:00 ET The "it factor." Some stocks have it. Others don't. But when you find stocks with the "it factor," you'll want to load up on them. Three Motley Fool contributors believe they've identified three stocks that fit the bill. Here's why they think CRISPR Therapeutics...

2024-03-29 09:59:07 ET Summary The diabetes and obesity markets are large and growing, with an estimated total long-term addressable market of $100 billion in the US alone. Denmark's Novo Nordisk and US-based Eli Lilly are leading pharmaceutical companies in the development of GLP...

2024-03-29 03:23:30 ET Summary Eli Lilly's stock price rise continues unabated in 2023, backed by strong topline growth in 2023 and a sunny outlook for 2024. Its diabetes treatments look particularly encouraging, with Mounjaro's 11x revenue increase last year and a great start to ...

2024-03-28 21:44:36 ET Summary The iShares Core S&P 500 ETF replicates the S&P 500 faithfully and has identical long-term performance at a .03% fee. IVV strikes a diversified balance between growth and value and is an excellent proxy for many of the best US companies. ...

2024-03-28 20:00:00 ET Summary A reader asked last week what was driving the S&P 500 earnings growth. The fact is the biggest market cap stocks, some of which have the larger earnings weights, are pushing the market higher. It’s a healthy economy, as evidenced by Q4 &#x...

2024-03-28 10:00:53 ET More on CVS, Elevance Health, etc. Elevance: A Healthy Dose Of Dividend Growth Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront CVS Health: Here Comes The Floor - Inherent Undervaluation Triggers Great Upside Potential ...

2024-03-28 09:30:13 ET Summary S&P 500 and its replica fund, SPDR S&P 500 ETF Trust, have seen positive performance in Q1 2024, and the potential for the top 10 holdings continues to indicate an upside. However, there are risks to consider when considering investing for re...